- MannKind (NASDAQ:MNKD) announced that Steven Binder will retire from his position as Chief Financial Officer, effective April 22, 2024.
- Christopher Prentiss has been appointed as CFO, effective April 22, 2024.
- Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
- Since September 2022, Prentiss has served as CFO of ADARx Pharmaceuticals, a privately held clinical-stage biotechnology company. He also held a series of finance positions at the commercial-stage biotech company Adamas Pharmaceuticals.